These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 26129880)

  • 1. A pro-inflammatory glycoprotein biomarker is associated with lower bilirubin in metabolic syndrome.
    Dullaart RP; Gruppen EG; Connelly MA; Lefrandt JD
    Clin Biochem; 2015 Nov; 48(16-17):1045-7. PubMed ID: 26129880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel protein glycan biomarker and LCAT activity in metabolic syndrome.
    Gruppen EG; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
    Eur J Clin Invest; 2015 Aug; 45(8):850-9. PubMed ID: 26081900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GlycA, a biomarker of inflammatory glycoproteins, is more closely related to the leptin/adiponectin ratio than to glucose tolerance status.
    Dullaart RP; Gruppen EG; Connelly MA; Otvos JD; Lefrandt JD
    Clin Biochem; 2015 Aug; 48(12):811-4. PubMed ID: 25977069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher circulating GlycA, a pro-inflammatory glycoprotein biomarker, relates to lipoprotein-associated phospholipase A2 mass in nondiabetic subjects but not in diabetic or metabolic syndrome subjects.
    Gruppen EG; Connelly MA; Dullaart RP
    J Clin Lipidol; 2016; 10(3):512-8. PubMed ID: 27206938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GlycA is a Novel Marker of Inflammation Among Non-Critically Ill Hospitalized Patients with Type 2 Diabetes.
    Dungan K; Binkley P; Osei K
    Inflammation; 2015; 38(3):1357-63. PubMed ID: 25586483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome.
    Deetman PE; Bakker SJ; Dullaart RP
    Cardiovasc Diabetol; 2013 Nov; 12():166. PubMed ID: 24209691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GlycA, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: PREVEND study.
    Connelly MA; Gruppen EG; Wolak-Dinsmore J; Matyus SP; Riphagen IJ; Shalaurova I; Bakker SJ; Otvos JD; Dullaart RP
    Clin Chim Acta; 2016 Jan; 452():10-7. PubMed ID: 26549655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inverse relation of HDL anti-oxidative functionality with serum amyloid a is lost in metabolic syndrome subjects.
    Dullaart RP; de Boer JF; Annema W; Tietge UJ
    Obesity (Silver Spring); 2013 Feb; 21(2):361-6. PubMed ID: 23404653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of the metabolic syndrome on high-sensitivity C reactive protein levels in patients with acute coronary syndrome.
    Kilic T; Jneid H; Ural E; Oner G; Sahin T; Kozdag G; Kahraman G; Ural D
    Atherosclerosis; 2009 Dec; 207(2):591-6. PubMed ID: 19577754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-sensitivity C-reactive protein in Japanese patients with type 2 diabetes.
    Tajiri Y; Mimura K; Umeda F
    Obes Res; 2005 Oct; 13(10):1810-6. PubMed ID: 16286529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel inflammatory biomarker, GlycA, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in BMI-matched controls.
    Bartlett DB; Connelly MA; AbouAssi H; Bateman LA; Tune KN; Huebner JL; Kraus VB; Winegar DA; Otvos JD; Kraus WE; Huffman KM
    Arthritis Res Ther; 2016 Apr; 18():86. PubMed ID: 27067270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do albuminuria and hs-CRP add to the International Diabetes Federation definition of the metabolic syndrome in predicting outcome?
    van der Velde M; Bello AK; Brantsma AH; El Nahas M; Bakker SJ; de Jong PE; Gansevoort RT
    Nephrol Dial Transplant; 2012 Jun; 27(6):2275-83. PubMed ID: 22231032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower serum paraoxonase-1 activity is related to higher serum amyloid a levels in metabolic syndrome.
    Kappelle PJ; Bijzet J; Hazenberg BP; Dullaart RP
    Arch Med Res; 2011 Apr; 42(3):219-25. PubMed ID: 21722818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Protein Glycan-Derived Markers of Systemic Inflammation and C-Reactive Protein in Relation to Glycemia, Insulin Resistance, and Insulin Secretion.
    Lorenzo C; Festa A; Hanley AJ; Rewers MJ; Escalante A; Haffner SM
    Diabetes Care; 2017 Mar; 40(3):375-382. PubMed ID: 28031420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GlycA, a Pro-Inflammatory Glycoprotein Biomarker, and Incident Cardiovascular Disease: Relationship with C-Reactive Protein and Renal Function.
    Gruppen EG; Riphagen IJ; Connelly MA; Otvos JD; Bakker SJ; Dullaart RP
    PLoS One; 2015; 10(9):e0139057. PubMed ID: 26398105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum high-sensitivity C-reactive protein as a biomarker in patients with metabolic syndrome: evidence-based study with 7284 subjects.
    Mirhafez SR; Ebrahimi M; Saberi Karimian M; Avan A; Tayefi M; Heidari-Bakavoli A; Parizadeh MR; Moohebati M; Azarpazhooh MR; Esmaily H; Nematy M; Safarian M; Ferns GA; Ghayour-Mobarhan M
    Eur J Clin Nutr; 2016 Nov; 70(11):1298-1304. PubMed ID: 27460263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppressive effects of valsartan on microalbuminuria and CRP in patients with metabolic syndrome (Val-Mets).
    Shishido T; Konta T; Nishiyama S; Miyashita T; Miyamoto T; Takasaki S; Nitobe J; Watanabe T; Takeishi Y; Kubota I
    Clin Exp Hypertens; 2011; 33(2):117-23. PubMed ID: 21269062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoprotein A and B Height-to-Width Ratios as Obesity-Independent Novel Biomarkers of Low-Grade Chronic Inflammation in Women with Polycystic Ovary Syndrome (PCOS).
    Fuertes-Martín R; Moncayo S; Insenser M; Martínez-García MÁ; Luque-Ramírez M; Grau NA; Blanchar XC; Escobar-Morreale HF
    J Proteome Res; 2019 Nov; 18(11):4038-4045. PubMed ID: 31503497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utility of a novel inflammatory marker, GlycA, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis.
    Ormseth MJ; Chung CP; Oeser AM; Connelly MA; Sokka T; Raggi P; Solus JF; Otvos JD; Stein CM
    Arthritis Res Ther; 2015 May; 17(1):117. PubMed ID: 25956924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of GlycA, a pro-inflammatory glycoprotein biomarker, associate with an increased risk of microvascular complications in patients with type 2 diabetes (Zodiac-62).
    Bourgonje AR; van der Vaart A; Gruppen EG; van Goor H; Bakker SJL; Connelly MA; van Dijk PR; Dullaart RPF
    Endocrine; 2023 May; 80(2):312-316. PubMed ID: 36757630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.